Universitätspublikationen
Refine
Year of publication
Document Type
- Article (12988)
- Part of Periodical (3425)
- Doctoral Thesis (3176)
- Contribution to a Periodical (2074)
- Book (2049)
- Working Paper (1869)
- Preprint (1297)
- Review (1050)
- Report (910)
- Conference Proceeding (659)
Language
- English (16256)
- German (13466)
- Portuguese (231)
- Spanish (123)
- Italian (66)
- French (64)
- Multiple languages (59)
- Turkish (12)
- Ukrainian (10)
- slo (7)
Has Fulltext
- yes (30316) (remove)
Keywords
- Deutschland (132)
- COVID-19 (93)
- inflammation (91)
- Financial Institutions (90)
- ECB (67)
- Capital Markets Union (64)
- SARS-CoV-2 (63)
- Financial Markets (61)
- Adorno (58)
- Banking Union (50)
Institute
- Medizin (6254)
- Präsidium (4968)
- Physik (3056)
- Wirtschaftswissenschaften (2234)
- Gesellschaftswissenschaften (2005)
- Biowissenschaften (1677)
- Frankfurt Institute for Advanced Studies (FIAS) (1454)
- Biochemie und Chemie (1371)
- Sustainable Architecture for Finance in Europe (SAFE) (1368)
- Informatik (1351)
Das Working Paper bietet die zusammenfassende Stellungnahme von Prof. Volker Wieland zum Ankaufprogramm der Europäischen Zentralbank für Anleihen des öffentlichen Sektors (Public Sector Purchase Programme, PSPP) am Bundesverfassungsgericht am 30.07.2019. Dabei liegt der Schwerpunkt auf der Frage der Einordnung des PSPP als monetäre, geldpolitische Maßnahme und der Verhältnismäßigkeit des Programms und seiner Umsetzung. Ebenfalls wird kurz auf die weiteren Fragen zur Umsetzung, insbesondere Ankündigung, Begrenzung und Abstand zum Primärmarkt für Staatsanleihen eingegangen.
The European Commission is trying to reboot the CMU project: The High-Level Forum on Capital Markets Union – a group of 28 selected experts from industry, academia and civil society – is expected to submit policy recommendations by the end of May 2020 which will feed into the Commission’s new CMU agenda. This contribution is largely based on a letter to the High-Level Forum that gives feedback on the Interim Report published in February. There, we introduce a comprehensive approach to distinguish, from a functional finance perspective, between the ‘game changers’ and what is nice to have. We highlight the importance of common and consistent supervisory practices across Member States and recommend building up a European Securities and Exchange Commission (E-SEC) according to the American model.
We study how the Eurosystem Collateral Framework for corporate bonds helps the European Central Bank (ECB) fulfill its policy mandate. Using the ECBs eligibility list, we identify the first inclusion date of both bonds and issuers. We find that due to the increased supply and demand for pledgeable collateral following eligibility, (i) securities lending market trading activity increases, (ii) eligible bonds have lower yields, and (iii) the liquidity of newly-issued bonds declines, whereas the liquidity of older bonds is una↵ected/improves. Corporate bond lending relaxes the constraint of limited collateral supply, thereby making the market more cohesive and complete. Following eligibility, bond-issuing firms reduce bank debt and expand corporate bond issuance, thus increasing overall debt size and extending maturity.
Acute and chronic inflammation play a pivotal role in various diseases, such as rheumatoid arthritis, atherosclerosis, bacterial as well as viral infections and therefore are an everyday-challenge in clinical practice. In this context, biologically active products of the cyclooxygenases and the prostanoid synthases, e.g. prostaglandins, critically contribute to various aspects of the inflammatory response in almost every tissue of the body. Emerging evidence over the past decades has demonstrated that these mediators are not only responsible for a pro-inflammatory response, but also show anti-inflammatory and pro-resolving properties. The relevance of biologically active lipids in this context is strengthened by the clinical efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs), e.g. Aspirin®, which block the biosynthesis of the mediators via the cyclooxygenase (COX) enzymes. Notably, microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E2 (PGE2) is a well-studied, functionally versatile PG, which promotes its effects via specific G protein-coupled receptors (GPCRs). Activation of these receptors elicits an internal signal transduction cascade, including activation of the adenylyl cyclase (AC). Active AC contributes to an elevated intracellular cyclic adenosine monophosphate (cAMP) level, which in turn activates the transcription factor cAMP response element-binding protein (CREB) via phosphorylation.
While the role of PGE2 in the inflammatory context has been well-documented in previous literature, relatively little is known about CREB-dependent transcriptional changes in inflammation. Therefore, the aim of this study was to investigate the effect of mPGES-1-derived PGE2 on CREB-mediated transcriptional changes specifically in murine wild-type (WT) and mPGES-1 knock-out (KO) macrophages in an inflammatory context. To address this issue, bone marrow-derived macrophages (BMDMs) were treated with either the bacterial cell wall component lipopolysaccharide (LPS) in combination with interferon-γ (IFN-γ) or the yeast extract zymosan. To analyze effects on CREB activation we determined protein expression profiles of relevant PGE2-synthesizing enzymes, i.e. COX-2 and mPGES-1, as well as activity of the downstream transcription factor CREB. The activity of mPGES-1 was simultaneously determined by the analysis of the prostanoid kinetics. Under these experimental conditions we showed that COX-2 is strongly induced, and we also observed elevated activated CREB levels in WT as well as in mPGES-1 KO macrophages. Further, both LPS+IFN-γ and zymosan increased expression of mPGES-1 in WT but not in mPGES-1-deficient macrophages. These findings go in hand with largely similar alterations in the PGD2, TXB2, PGF2α profiles in WT and mPGES-1 KO macrophages upon stimulation. Of note, an elevated PGE2 production was also observed in mPGES-1-deficient macrophages at later stages upon inflammatory conditions. Subsequently, potential CREB-regulated targets were identified in macrophages upon inflammatory stimuli after 16 h by chromatin immunoprecipitation (ChIP) followed by Next-Generation-Sequencing (NGS). Surprisingly, despite equal levels of pCREB the characterization of CREB binding sites revealed different targetome profiles between WT and mPGES-1 KO macrophages. Specifically, the fatty acid metabolic processes-associated targets appeared to be selectively lost in mPGES-1-deficient vs. WT macrophages. We further validated one of those targets, i.e. the endoplasmic reticulum lipid raft-associated protein 1 (Erlin1), at the mRNA expression level, which indeed was differentially transcribed in response to different PGE2 synthesizing conditions.
Mechanistically, CREB is a well-characterized phosphorylation-dependent transcription factor in cell survival, proliferation, differentiation, and immune responses. Yet, our understanding of the functions of CREB in inflammation, specifically with respect to its activation by PGE2, is insufficient. Due to its biological relevance in inflammation it clearly requires additional studies to shed light on the details of CREB activation in macrophages to provide possibilities of therapeutic interventions.
The electron transport chain (ETC) is used by cells to create an electrochemical proton gradient which can be used by the ATP synthase to produce ATP. ETC, also called respiratory chain, is formed in mitochondria by four complexes (complex I-IV) and mediated by two electron carriers: cytochrome c and ubiquinone. Electrons are passed from one complex to another in a series of redox reactions coupling proton pumping from the negative (N) side of the membrane to the positive (P) side. Complex I can introduce electrons into the ETC by oxidizing NADH to NAD+ and reducing quinone (Q) to quinol (QH2). The process accomplishes pumping of four protons across the membrane. Complex II is another electrons entry point. It catalyzes the oxidation of succinate to fumarate while reducing Q to QH2. Complex III, also called cytochrome bc1 complex, can transfer the electrons from QH2 to cytochrome c and couple to proton pumping. In complex III the Q-cycle contributes four proton translocations: two protons are required for the reduction of one quinone to a quinol and two protons are released to the P side. Complex IV (cytochrome c oxidase), the terminal complex of the ETC, catalyzes the electron transfer to oxygen and pumps four protons to the P side. Structures of ETC complexes are available. However, the structure of a hyperthermophilic cytochrome bc1 complex has not been elucidated till now. Additionally, the dimeric crystal structure of cytochrome c oxidase from bovine has been discussed controversially.
To build up a functional complex, cofactors are required. The active site of A- and B-type cytochrome c oxidases contain the high spin heme a which is synthesized by the integral membrane protein heme A synthase (HAS). HAS can form homooligomeric complexes and its oligomerization is essential for the biological function of HAS. HAS is evolutionarily conserved among prokaryotes and eukaryotes. Despite its importance, little is known about the detailed structural properties of HAS oligomers.
During my PhD studies, I focused on the cytochrome c oxidase (AaCcO), the cytochrome bc1 complex (Aabc1) and the heme A synthase (AaHAS) from Aquifex aeolicus. This organism is one of the most hyperthermophilic ones and can live at extremely high temperatures, even up to 95 °C. Respiratory chain complexes provide energy for the metabolism of organisms, and their structures have been studied extensively in the past few years. However, there has been a lack of atomic structures of complexes from hyperthermophilic and ancient bacteria, so little is known about the mechanism of these macromolecular machines under hyperthermophilic conditions. Therefore, my PhD studies had four main objectives: 1) to structurally and functionally characterize AaCcO, 2) to reveal the mechanism of Aabc1 thermal stability based on its structure, 3) to determine the oligomerization of AaHAS, 4) to provide valuable insights into the relationship between function and oligomerization of AaHAS.
1) Structure of AaCcO
Heme-copper oxidases (HCOs) catalyze the oxygen reduction reaction being the terminal enzymes in the plasma membranes in many prokaryotes or of the aerobic respiratory chain in the inner mitochondrial membrane. By coupling this exothermic reaction to proton pumping across the membrane to the P side, they contribute to the establishment of an electrochemical proton gradient. The energy in the proton electrochemical proton gradient is used by the ATP synthase to generate ATP. HCOs are classified into three major families: A, B and C, based on phylogenetic comparisons. The well-studied aa3-type cytochrome c oxidase from Paracoccus denitrificans (P. denitrificans) represents A-family HCOs. So far, the only available structure of the ba3-type cytochrome c oxidase from Thermus thermophilus represents the B-family of HCOs. This family contains a number of bacterial and archaeal oxidases. The C-family contains only cbb3-type cytochrome c oxidases.
The AaCcO is one of the ba3-type cytochrome c oxidases. Based on the genomic DNA sequence analysis, it has been revealed that A. aeolicus possesses two operons coding for cytochrome c oxidases (two different subunit I genes, two different subunit II genes and one subunit III gene). So far, only subunits CoxB2 and CoxA2 were identified. The presence of the additional subunit IIa was reported in 2012. Moreover, a previous paper reported that AaCcO can use horse heart cytochrome c and decylubiquinol as electron donors and the typical cytochrome c oxidase inhibitor cyanide does not block the reaction completely.
In the course of my PhD studies, I performed heterologous expression of AaCcO in Pseudomonas stutzeri (P. stutzeri) and co-expression with AsHAS in Escherichia coli, respectively. The subcomplex CoxA2 and CoxB2 can be purified from P. stutzeri, however, it lacks heme A. Additionally, a protocol for the heterologous production of cytochrome c555 from A. aeolicus was established. In parallel, I also purified the AaCcO from native membranes according to previously reported methods with some modifications. The activity of AaCcO with its native substrate, cytochrome c555, was 14 times higher than with horse heart cytochrome c.
To enable a detailed investigation and comparison of AaCcO and other cytochrome c oxidases, the cryo-EM structure of AaCcO was determined to 3.4 Å resolution. It shows that the three subunits CoxA2, CoxB2, and IIa are tightly bound together to form a dimer in the membrane. Surprisingly, CoxA2 contains two additional TMHs (TMH13 and TMH14) to enhance the protein stability. The cofactors heme a3, heme b, CuA and CuB are also identified. Interestingly, two molecules of 1,4-naphthoquinone and cardiolipin were observed in the dimer interface. Based on the structure analysis, the AaCcO possesses only the K-pathway for proton delivery to the active site and proton pumping.
...
Aufgrund des großen Potenzials der Nanotechnologie ist in Zukunft eine Zunahme der Produktion und Verwendung von Nanomaterialien zu erwarten, wodurch mit einer steigenden Freisetzung in der Umwelt zu rechnen ist. In der vorliegenden Dissertation werden daher Methoden zur Untersuchung von Nanomaterialien betrachtet und Effekte von NP auf Algen untersucht.
In Teil I wurden Silber-, Titandioxid- und Polystyrol-Nanopartikel sowie Kohlenstoffnano-röhrchen untersucht. Von jedem Nanomaterial standen eine unmodifizierte Form sowie zwei modifizierte Partikeltypen mit geladener Oberfläche und zusätzlich Polystyrol-Mikropartikel zur Verfügung. Zunächst erfolgte eine Charakterisierung der Materialien mittels Transmissions-elektronenmikroskopie, wobei die Größe der Objekte gemessen und das Verhalten beschrieben wurde. Zudem wurde im Fall der Polystyrol-Nanopartikel der Einfluss mehrerer Chemikalien getestet, welche im Zusammenhang mit der Probenvorbereitung für das Elektronen¬mikroskop zum Einsatz kamen. In einem nächsten Schritt erfolgte die Untersuchung von Nanomaterialien in umweltrelevanten Matrices. Hierbei wurden Boden- und Wasserproben sowie humane Körperflüssigkeiten und Fischgewebe elektronenmikroskopisch auf die Anwesenheit von synthetischen Nanomaterialien untersucht und Proben mit Nanomaterialien versetzte, um die Nachweisbarkeit mit dem Elektronenmikroskop bewerten zu können. Zusätzlich wurden verschiedene Zellkulturen und Gewebe auf morphologische Auffälligkeiten im Zusammenhang mit einer Exposition gegenüber Nanomaterialien untersucht.
Die durchgeführten Versuche zeigen, dass die Transmissionselektronenmikroskopie für viele Nanomaterialien ein sinnvolles Charakterisierungswerkzeug darstellt. Die Untersuchung besonders kleiner Partikel mit einem Durchmesser im einstelligen Nanobereich gestaltet sich jedoch schwierig bis unmöglich. Für den Nachweis von Nanomaterialien in Umweltmatrices und Zellen ist die Methode nur bedingt geeignet, wobei insbesondere niedrige Partikelkonzentrationen problematisch sind. Die Methode ist somit lediglich als Ergänzung zu anderen Nachweismethoden zu betrachten, kann jedoch hilfreiche Informationen zur Lokalisation von Nanoobjekten in Zellen und zu ihrem Verhalten in Umweltproben liefern.
In Teil II wurden die beiden Grünalgen Raphidocelis subcapitata und Chlamydomonas reinhardtii sowie die Diatomee Cyclotella meneghiniana gegenüber unterschiedlich modifizierten Silber-, Titandioxid- und Polystyrol-Nanopartikeln exponiert. Die Beurteilung der Toxizität wurde anhand der über die Absorption gemessenen Zellzahl, des Chlorophyll a Gehalts, der über die Chlorophyllfluoreszenz gemessenen Parameter Fv/Fm und NPQ sowie der transmissions¬elektronenmikroskopischen Untersuchung der Algenzellen vorgenommen. Zudem wurde der Einfluss der Beschattung von Algenzellen durch die Nanopartikel experimentell untersucht.
Die Untersuchungen zeigen, dass Nanomaterialien bei Absorptionsmessungen in Abhängigkeit von ihrem Grundmaterial, ihrer Oberflächenmodifikation und dem umgebenden Medium ein mehr oder weniger starkes Streuungsverhalten zeigen. Auch die Anwesenheit von Algen kann einen deutlichen Einfluss haben. Trotz der Beeinflussung der Lichtstreuung hat die Beschattung von Algen durch die Trübung des Mediums durch Nanomaterialien keinen Einfluss auf das Wachstum der Testorganismen. Die direkte Exposition der Algen gegenüber den Nanomaterialien zeigt, dass Silber-Nanopartikel die toxischste Wirkung haben. Die Abgabe von Silberionen durch die Partikel kann hierbei die auftretenden Effekte erklären. Auch Titandioxid-Nanopartikel führen zu negativen Effekten, wobei mögliche Gründe die Toxizität des Materials und die physikalische Isolierung der Zellen sind. Die Polystyrol-Nanopartikel haben eine stimulierende Wirkung auf die Algenzellen, welche auf einer Präferenz von adhäsivem Wachsen und dem Hormesis-Effekt beruhen kann. Die Oberflächenmodifikation der Nanomaterialien hat zwar einen Effekt auf die Toxizität, ihr Einfluss wird jedoch durch andere Faktoren überlagert. In Bezug auf die unterschiedlichen Methoden zum Nachweis der Toxizität, ist die Bestimmung des Chlorophyll a-Gehalts als besonders sensitiv zu bewerten und kann zudem auf alle Partikel angewandt werden. Hinsichtlich der Absorptionsmessung besteht teilweise ein Einfluss durch die Partikelstreuung. Die Messung der Chlorophyllfluoreszenz scheint einer starken Beeinflussung durch externe Faktoren und ggf. die Nanomaterialien selbst zu unterliegen. Die elektronenmikroskopische Untersuchung ist vergleichsweise wenig sensitiv, kann jedoch ergänzende Informationen bezüglich der Wirkweise von Nanomaterialien liefern. Der Vergleich der Testorganismen zeigt, dass Raphidocelis subcapitata empfindlicher reagiert als Chlamydomonas reinhardtii. Eine allgemeingültige Sensitivitätsabstufung zwischen den Grünalgen und der Diatomee ist nicht möglich, da die Reaktionen in Abhängigkeit von Medium bzw. Partikelgrundmaterial unterschiedlich ausfallen.
The RNA cleaving catalyst tris(2-aminobenzimidazole) when attached to the 5’ terminus of oligonucleotides cuts complementary RNA strands in a highly site-specific manner. Conjugation was previously achieved by the acylation of an amino linker by an active ester of the catalyst. However, this procedure was low yielding and not reliable. Here, a phosphoramidite building block is described that can be coupled to oligonucleotides by manual solid phase synthesis in total yields around 85%. Based on this chemistry, we have now studied the impact of LNA (locked nucleic acids) nucleotides on the rates and the site-specificities of RNA cleaving conjugates. The highest reaction rates and the most precise cuts can be expected when the catalyst is attached to a strong 5’ closing base pair and when the oligonucleotide contains several LNA units that are equally distributed in the strand. However, when placed in the 5’ position, LNA building blocks tend to diminish the specificity of RNA cleavage.
RNA-protein complexes (RNPs) are essential components in a variety of cellular processes, and oftentimes exhibit complex structures and show mechanisms that are highly dynamic in conformation and structure. However, biochemical and structural biology approaches are mostly not able to fully elucidate the structurally and especially conformationally dynamic and heterogeneous nature of these RNPs, to which end single molecule Förster resonance energy transfer (smFRET) spectroscopy can be harnessed to fill this gap. Here we summarize the advantages of strategic smFRET studies to investigate RNP dynamics, complemented by structural and biochemical data. Focusing on recent smFRET studies of three essential biological systems, we demonstrate that investigation of RNPs on a single molecule level can answer important functional questions that remained elusive with structural or biochemical approaches alone: The complex structural rearrangements throughout the splicing cycle, unwinding dynamics of the G-quadruplex (G4) helicase RHAU, and aspects in telomere maintenance regulation and synthesis.
Patient therapy is based mainly on a combination of diagnosis, suitable monitoring or support devices and drug treatment and is usually employed for a pre-existing disease condition. Therapy remains predominantly symptom-based, although it is increasingly clear that individual treatment is possible and beneficial. However, reasonable precision medicine can only be realized with the coordinated use of diagnostics, devices and drugs in combination with extensive databases (4Ds), an approach that has not yet found sufficient implementation. The practical combination of 4Ds in health care is progressing, but several obstacles still hamper their extended use in precision medicine.